fluorobenzenes has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Kruif, MD; de Ruiter, J; Hansen, HR; Limper, M; Meesters, EW; Rowshani, AT; Spek, CA; ten Berge, IJ; ten Cate, H; van Gorp, EC | 1 |
| Lai, JP; Lam, CS; Mok, CC; To, CH; Wong, CK | 1 |
2 trial(s) available for fluorobenzenes and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.
Topics: C-Reactive Protein; Cross-Over Studies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lupus Erythematosus, Systemic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2009 |
Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Double-Blind Method; Female; Fluorobenzenes; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thrombomodulin | 2011 |